You are here: Industry Insights > Acquisition

News List

Cambrex Buys Avista for $252M contractpharma
November 27, 2018
Cambrex has entered into a definitive agreement to acquire Avista Pharma Solutions for roughly $252 million. Avista is a portfolio company of Ampersand Capital Partners.
Telix to Acquire ANMI for €5.15M contractpharma
November 27, 2018
Telix Pharmaceuticals Limited has announced the acquisition of Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares.
Exscientia builds AI capability with Kinetic acquisition pharmaphorum
November 27, 2018
There is huge focus on the potential of artificial intelligence (AI) in drug discovery – and Exscientia is another UK company building its capability in this area.
Sun gets dermatology portfolio, two plants in Japan with Pola Pharma deal expressbpd
November 27, 2018
Acquisition to help in building global dermatology business
Sun Pharma to acquire Japan’s Pola Pharma through arm financialexpress
November 27, 2018
Sun Pharma forayed into the Japanese prescription market in 2016 with the acquisition of 14 established prescription brands from Novartis.
BTG chief Dame Louise Makin in line for £20m windfall after firm's sale dailymail
November 26, 2018
The woman who turned BTG into a diverse pharmaceuticals and life sciences company could bank up to £20million from its takeover.....
With EU blessing, Takeda clears final regulatory hurdle for Shire buyout—on one condition fiercepharma
November 26, 2018
Following major regulators in the U.S., China and Japan, the European Commission has given Takeda the go-ahead for its $62 billion acquisition of Shire—on one condition that Takeda is willing to fulfill.
Grunenthal Acquires Averitas Pharmal and Establishes Commercial Footprint in the US pharmafocusasia
November 26, 2018
Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial ....
Innovus Pharmaceuticals Acquires Worldwide Rights to Four Products from Boston Topicals, LLC pharmafocusasia
November 26, 2018
We continue to bolster our product pipeline with clinically and commercially validated products that fit both our direct to consumer channels as well as retail....
With EU blessing, Takeda clears final regulatory hurdle for Shire buyout—on one condition fiercepharma
November 22, 2018
Following major regulators in the U.S., China and Japan, the European Commission has given Takeda the go-ahead for its $62 billion acquisition of Shire—on one condition that Takeda is willing to fulfill.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page